Research

Elsevier,

Current Opinion in Chemical Biology, Volume 64, October 2021

A review of potential inhibitors of amyloid protein aggregation, one of the causes of neurodegredation.
Elsevier,

Prostaglandins and Other Lipid Mediators, Volume 156, October 2021

This review focuses on the role of 7-ketocholesterol (7KCh) mediated neurodegenerative Alzheimer’s disease with emphasis on alterations in the lipid raft microdomain. In addition, current trends in the significant therapies related to 7KCh inhibition are highlighted.
Elsevier,

Bioorganic and Medicinal Chemistry Letters, Volume 49, 1 October 2021

An evaluation of the pharmacological potency of 2 agents which may lead to the development of treatment for Alzheimer's.
Elsevier,

Current Opinion in Chemical Biology, Volume 64, October 2021

A review of peptide model systems used to investigate and understand the structures, biological properties, and biophysical properties of amyloid oligomers linked to diseases such as Alzheimers.
Elsevier,

Current Opinion in Chemical Biology, Volume 64, October 2021

A review of recent advances in protein chemistry, biophysics, advanced imaging, and proteomics and the way they could be applied to decipher and embrace the complexity of protein aggregation and pathology formation. This may advance translational research and drug discovery in neurodegenerative diseases.
Elsevier,

Food Quality and Preference, Volume 93, October 2021, 104267

Contributing to SDGs 2, 12 and 13, this article provides an overview of the sustainability motives consumers have for selecting their food.
Elsevier,

Ageing Research Reviews, Volume 70, September 2021

Multiple factors such genetics, metabolism, and lifestyle factors are involved in both COVID-19 and Alzheimer’s disease.
Elsevier,

Behavioural Brain Research, Volume 414, 24 September 2021

Studies have shown that the RhoA/ROCK signaling pathway can promote Alzheimer's disease and therefore, ROCK is a promising drug target in AD.
Elsevier,

14th September 2021

World Alzheimer's Day is an international campaign organised by Alzheimer's Disease International to raise awareness and highlight issues faced by people affected by dementia. It takes place every year on September 21st and is the focus of World Alzheimer's Month. In support of this year’s theme – ‘Know dementia, know Alzheimer's’ - Elsevier presents a curated, open access collection of over 70 journal articles and book chapters focused on shining a light on the warning signs of dementia and the importance of a timely diagnosis.
Elsevier,

Wellbeing, Space and Society, Volume 2, September 2021, 100046

To address SDG 3 target 3.4 (By 2030, reduce by one third premature mortality form non-communicable diseases through prevention and treatment and promote mental health and well-being), strengthening the delivery of mental healthcare to the most vulnerable populations is critical. This paper explores the experiences of staff working in the National Health Service (NHS) offender health teams to identify sources of adversity that frontline staff encounter when providing healthcare in prison settings. The results highlight sources of adversity that need to be addressed in order to ensure the wellbeing of mental healthcare providers and enable high quality delivery of healthcare to vulnerable populations.

Pages